Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Growth Outlook Reveals A CAGR Of 23.3% And A Market Value Of $4.37 Billion By 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Revenue Outlook: What CAGR Is Expected Through 2030?
The market for artificial intelligence powered tools used in assessing clinical trial site feasibility has experienced remarkable expansion. Projections indicate a significant increase from its 2025 valuation of 1.53 billion dollars to 1.89 billion dollars by 2026, reflecting a compound annual growth rate of 23.6%. This trajectory of growth throughout the historical period is fueled by several key factors: the escalating complexity inherent in clinical trial designs, mounting cost imperatives associated with drug development schedules, a heightened dependence on data to inform trial planning strategies, the proliferation of international multi site clinical trials, and the early integration of predictive analytics into the feasibility assessment process.
The market for artificial intelligence (AI) solutions designed to assess clinical trial site feasibility is projected to experience substantial expansion in the coming years, reaching an estimated $4.38 billion by 2030, driven by a compound annual growth rate of 23.3%. This accelerated growth trajectory is anticipated due to several key factors, including the increasing implementation of decentralized clinical trial models, a heightened need for expedited site activation processes, a greater reliance on real-world evidence for making informed feasibility determinations, the proliferation of AI-powered trial planning instruments, and a strengthened commitment to minimizing trial-related risks. Within this forecast period, significant trends are expected to shape the landscape, such as the wider embrace of AI-driven methodologies for site selection, a surge in the utilization of predictive analytics for patient recruitment, the deeper incorporation of real-world data into feasibility evaluations, the advancement and adoption of cloud-based feasibility platforms, and a more pronounced concentration on forecasting trial performance metrics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp
#Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Demand Drivers Creating New Revenue Opportunities
The surge in clinical trials is anticipated to be a primary catalyst for the advancement of the artificial intelligence (AI)-enabled clinical trial site feasibility sector. Clinical trials, which are research investigations undertaken worldwide to assess the safety and effectiveness of novel medical interventions, pharmaceuticals, and equipment, are experiencing an uptick. This expansion in clinical trial activity stems from amplified funding directed towards biomedical research and development, as governmental and commercial entities alike acknowledge the crucial necessity of novel therapeutic approaches to combat escalating health concerns. The proliferation of clinical trials consequently fuels a demand for AI-driven solutions designed for site feasibility, empowering research entities to pinpoint ideal study locations, evaluate the proficiency of these sites, and forecast the likelihood of participant enrollment for their trials. To illustrate, as of April 2025, the clinicaltrials.gov platform listed a total of 404,637 interventional clinical trials, according to data from the Multidisciplinary Digital Publishing Institute, a Swiss-based open-access scientific journal publisher. Consequently, this burgeoning landscape of clinical trials is directly contributing to the expansion of the AI-powered clinical trial site feasibility market.
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Categorization By Product Type And Application
The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users
Subsegments:
1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software
2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Trends Driving Strategic Industry Expansion
Leading participants in the AI-driven clinical trial site feasibility sector are prioritizing the creation of sophisticated tools, notably an AI-powered platform for feasibility and recruitment, aimed at refining site selection processes and elevating the general operational effectiveness of clinical studies. This type of platform utilizes artificial intelligence and machine learning to meticulously analyze trial protocols and site-specific data, thereby pinpointing the most suitable clinical locations and bolstering patient recruitment by intelligently connecting suitable individuals, ultimately expediting trial durations and improving study outcomes. As an illustration, in June of 2023, ObjectiveHealth, a technology and research solutions provider headquartered in the United States, introduced ObjectiveScreen, an AI-centric platform engineered to boost clinical trial performance. This system achieves this by improving patient identification, pre-qualification, and retention through seamless integration with electronic health records and the application of AI and machine learning techniques, thereby enabling clinical research sites to directly access patient information, assess health risks, and identify the most appropriate participants, leading to faster enrollment and better trial results.
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Company Landscape And Strategic Competition
Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI
Access The Complete Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report:
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Regional Outlook: Where Are The Largest Opportunities Located?
North Americawas the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
